» Articles » PMID: 15367612

Memory T-cell-mediated Immune Responses Specific to an Alternative Core Protein in Hepatitis C Virus Infection

Abstract

In vitro studies have described the synthesis of an alternative reading frame form of the hepatitis C virus (HCV) core protein that was named F protein or ARFP (alternative reading frame protein) and includes a domain coded by the +1 open reading frame of the RNA core coding region. The expression of this protein in HCV-infected patients remains controversial. We have analyzed peripheral blood from 47 chronically or previously HCV-infected patients for the presence of T lymphocytes and antibodies specific to the ARFP. Anti-ARFP antibodies were detected in 41.6% of the patients infected with various HCV genotypes. Using a specific ARFP 99-amino-acid polypeptide as well as four ARFP predicted class I-restricted 9-mer peptides, we show that 20% of the patients display specific lymphocytes capable of producing gamma interferon, interleukin-10, or both cytokines. Patients harboring three different viral genotypes (1a, 1b, and 3) carried T lymphocytes reactive to genotype 1b-derived peptides. In longitudinal analysis of patients receiving therapy, both core and ARFP-specific T-cell- and B-cell-mediated responses were documented. The magnitude and kinetics of the HCV antigen-specific responses differed and were not linked with viremia or therapy outcome. These observations provide strong and new arguments in favor of the synthesis, during natural HCV infection, of an ARFP derived from the core sequence. Moreover, the present data provide the first demonstration of the presence of T-cell-mediated immune responses directed to this novel HCV antigen.

Citing Articles

Sero-reactivity to three distinct regions within the hepatitis C virus alternative reading frame protein (ARFP/core+1) in patients with chronic HCV genotype-3 infection.

Elsheikh M, McClure C, Tarr A, Irving W J Gen Virol. 2022; 103(3).

PMID: 35230930 PMC: 9176264. DOI: 10.1099/jgv.0.001727.


Resourcing, annotating, and analysing synthetic peptides of SARS-CoV-2 for immunopeptidomics and other immunological studies.

Li C, Revote J, Ramarathinam S, Chung S, Croft N, Scull K Proteomics. 2021; 21(17-18):e2100036.

PMID: 33811468 PMC: 8250278. DOI: 10.1002/pmic.202100036.


A Novel Cis-Acting RNA Structural Element Embedded in the Core Coding Region of the Hepatitis C Virus Genome Directs Internal Translation Initiation of the Overlapping Core+1 ORF.

Vassilaki N, Frakolaki E, Kalliampakou K, Sakellariou P, Kotta-Loizou I, Bartenschlager R Int J Mol Sci. 2020; 21(18).

PMID: 32972019 PMC: 7554737. DOI: 10.3390/ijms21186974.


Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames.

Zanker D, Oveissi S, Tscharke D, Duan M, Wan S, Zhang X J Immunol. 2019; 202(12):3370-3380.

PMID: 31092636 PMC: 6681668. DOI: 10.4049/jimmunol.1900070.


Relationship between antibodies to hepatitis C virus core+1 protein and treatment outcome.

Mylopoulou T, Papadopoulos V, Kassela K, Karakasiliotis I, Souvalidou F, Mimidis P Ann Gastroenterol. 2018; 31(5):593-597.

PMID: 30174396 PMC: 6102464. DOI: 10.20524/aog.2018.0290.


References
1.
Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T . Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A. 1990; 87(24):9524-8. PMC: 55204. DOI: 10.1073/pnas.87.24.9524. View

2.
Soguero C, Joo M, Chianese-Bullock K, Nguyen D, Tung K, Hahn Y . Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J Virol. 2002; 76(18):9345-54. PMC: 136450. DOI: 10.1128/jvi.76.18.9345-9354.2002. View

3.
Hahn Y, Braciale V, Braciale T . Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the.... J Exp Med. 1991; 174(3):733-6. PMC: 2118934. DOI: 10.1084/jem.174.3.733. View

4.
Li J, Tong S, Vitvitski L, LEPOT D, Trepo C . Two French genotypes of hepatitis C virus: homology of the predominant genotype with the prototype American strain. Gene. 1991; 105(2):167-72. DOI: 10.1016/0378-1119(91)90147-4. View

5.
Diepolder H, Zachoval R, Hoffmann R, Wierenga E, Santantonio T, Jung M . Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 1995; 346(8981):1006-7. DOI: 10.1016/s0140-6736(95)91691-1. View